These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 22354524)
1. A prospective, multi-center study: factors related to the management of diabetic foot infections. Ertugrul BM; Oncul O; Tulek N; Willke A; Sacar S; Tunccan OG; Yilmaz E; Kaya O; Ozturk B; Turhan O; Yapar N; Ture M; Akin F Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2345-52. PubMed ID: 22354524 [TBL] [Abstract][Full Text] [Related]
2. The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey. Hatipoglu M; Mutluoglu M; Uzun G; Karabacak E; Turhan V; Lipsky BA Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):871-8. PubMed ID: 24452966 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study. Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of diabetic foot infections. Lipsky BA; Berendt AR; Deery HG; Embil JM; Joseph WS; Karchmer AW; LeFrock JL; Lew DP; Mader JT; Norden C; Tan JS; Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):212S-238S. PubMed ID: 16799390 [TBL] [Abstract][Full Text] [Related]
5. Diabetic Foot Infections: an Update in Diagnosis and Management. Grigoropoulou P; Eleftheriadou I; Jude EB; Tentolouris N Curr Diab Rep; 2017 Jan; 17(1):3. PubMed ID: 28101794 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the Risk Factors of Multidrug-Resistant Organism Infection in Adults With Type 1 or Type 2 Diabetes and Diabetic Foot Ulcer. Dai J; Jiang C; Chen H; Chai Y Can J Diabetes; 2020 Jun; 44(4):342-349. PubMed ID: 32005564 [TBL] [Abstract][Full Text] [Related]
7. [Diabetic foot osteomyelitis: is conservative treatment possible?]. Jordano-Montañez Q; Muñiz-Tatay M; Viadé-Julià J; Jaen-Manzanera A; Royo-Serrando J; Cuchí-Burgos E; Anglada-Barceló J; de la Sierra-Iserte A Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):555-9. PubMed ID: 24913994 [TBL] [Abstract][Full Text] [Related]
8. Antibiotic therapy for diabetic foot infections in a tertiary care hospital in Jakarta, Indonesia. Radji M; Putri CS; Fauziyah S Diabetes Metab Syndr; 2014; 8(4):221-4. PubMed ID: 25311820 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. Kandemir O; Akbay E; Sahin E; Milcan A; Gen R J Infect; 2007 May; 54(5):439-45. PubMed ID: 17018235 [TBL] [Abstract][Full Text] [Related]
11. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Lipsky BA; Holroyd KJ; Zasloff M Clin Infect Dis; 2008 Dec; 47(12):1537-45. PubMed ID: 18990064 [TBL] [Abstract][Full Text] [Related]
12. [Distribution of pathogens in diabetic foot osteomyelitis and risk factors of osteomyelitis]. Huang Y; Cao Y; Zou M; Li W; Luo X; Jiang Y; Xue Y; Gao F Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1782-6. PubMed ID: 26714916 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of femoral intra-arterial administration of teicoplanin in gram-positive diabetic foot infections. Dorigo B; Cameli AM; Trapani M; Raspanti D; Torri M; Mosconi G Angiology; 1995 Dec; 46(12):1115-22. PubMed ID: 7495317 [TBL] [Abstract][Full Text] [Related]
14. [Microbiology of diabetic foot infections: role of ertapenem]. Lima AL; Oliveira PR; Carvalho VC; Peixoto de Miranda EJ Drugs Today (Barc); 2013 May; 49 Suppl A():1-20. PubMed ID: 23724414 [TBL] [Abstract][Full Text] [Related]
16. Diabetic Foot Infection: Causative Pathogens and Empiric Antibiotherapy Considerations-The Experience of a Tertiary Center. Neves JM; Duarte B; Pinto M; Formiga A; Neves J Int J Low Extrem Wounds; 2019 Jun; 18(2):122-128. PubMed ID: 31035803 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males. Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650 [TBL] [Abstract][Full Text] [Related]
18. Microbiological and clinical characteristics of diabetic foot infections in northern India. Tiwari S; Pratyush DD; Dwivedi A; Gupta SK; Rai M; Singh SK J Infect Dev Ctries; 2012 Apr; 6(4):329-32. PubMed ID: 22505442 [TBL] [Abstract][Full Text] [Related]